WHO Prequalifies Celltrion’s Rituximab

Truxima Becomes Second Biosimilar To Be Prequalified By Organization

 
• By Dave Wallace

Celltrion’s Truxima has become the first rituximab biosimilar, and just the second biosimilar overall, to be prequalified by the WHO.

WHO
The WHO has prequalified Celltrion’s Truxima rituximab biosimilar • Source: Shutterstock

More from Biosimilars

More from Products